Live Breaking News & Updates on Second Line Treatment With Axicabtagene Ciloleucel

Stay updated with breaking news from Second line treatment with axicabtagene ciloleucel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Second-Line Axi-Cel Elicits Complete Metabolic Responses in Transplant-Ineligible LBCL

Second-line treatment with axicabtagene ciloleucel led to an investigator-assessed, 3-month complete metabolic response rate of 71.0% in patients with large B-cell lymphoma who were ineligible for autologous stem cell transplant. ....

Francois Lemonnier , International Prognostic Index , Lymphoid Malignancies Unit , Henri Mondor University Hospital , Ann Arbor , Second Line Treatment With Axicabtagene Ciloleucel , Patients With Largeb Cell Lymphoma , Alycante Trial ,